2m 2m 2m 2m 2m 2m 2m
ABIVAX SP ADS (ABVX)
NASDAQ
$136.57+$0.59 (+0.43%)
Price as of Jul 14, 2026 5:48 AM EDT- $11.9BMarket Cap
- 1,439.98%1-Year Change
- BiotechnologyIndustry
ABIVAX SP ADS (ABVX)
$136.57+$0.59 (+0.43%)
ABVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $135.98 | ||
Change | -$3.92 (-2.80%) | ||
Open | $137.29 | ||
High | $138.75 | ||
Low | $134.60 | ||
Previous Close | $139.90 | ||
Volume | 1,034,979 | ||
30-Day Average Volume | 2,544,509 | ||
1-Week Change | -5.56% | ||
1-Month Change | 40.84% | ||
1-Year Change | 1,439.98% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 87.2M | ||
Total Assets | $584.3M | ||
Market Cap | $11.9B | ||
Enterprise Value | $11.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue